FdaApplication
BLA 761261
Identifiers
- fda_app_no: BLA761261
Properties
| Property | Value |
|---|---|
| applicant_name | Genzyme Corporation |
| application_type | BLA |
| approval_date | 2022-08-31 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| XENPOZYME | OLIPUDASE ALFA-RPCP | 20MG | For Injection |
| XENPOZYME | — | 4MG | For Injection |
2 products